We investigated the effects of mesenchymal stem cells (MSCs) on wound healing using a three-dimensional (3D) collagen gel scaffold. Three circular full-thickness skin defects were created on the back of Sprague-Dawley rats. One site was covered with a 3D collagen gel containing 2 × 10 6 MSCs (MSCs+/3D collagen+). Another site was replaced with a 3D collagen gel without MSCs and the third site was left empty. The wound size was significantly reduced in the MSCs+/3D collagen+ sites. MSCs+/3D collagen+ sites exhibited the most neovascularization. FISH showed that Y-chromosome possessing cells were found within the dermis of MSCs+/3D collagen+ sites. Gelatin zymography revealed that the most intense expression of MMP-9 was detected early in the MSCs+/3D collagen+ sites. Our results indicate that MSCs upregulate the early expression of MMP-9 which induces the early mobilization of VEGF. Thus, MSCs appear to accelerate significantly wound healing via early activation of MMP-9 and VEGF.
INTRODUCTION
Wound healing requires the complex biomolecular processes of cell migration, proliferation, angiogenesis, and extracellular matrix remodeling (1, 2) . This process involves various cells, growth factors, and the extracellular matrix (ECM). During wound healing, cell migration and tissue remodeling necessitate degradation of ECM and release of growth factors (3) . The proteolytic degradation of ECM is achieved by extracellular proteases involving the matrix metalloproteinases (MMPs). These MMPs, particularly MMP-9, are thought to play a critical role in degrading ECM to facilitate the necessary initial steps for angiogenesis. The high expression of MMPs stimulates the angiogenic response, subsequently promoting the process of wound healing.
Angiogenesis is subjected to a complex control system with pro-angiogenic and anti-angiogenic factors. One of the most important pro-angiogenic factors is vascular endothelial growth factor (VEGF). During the early period of wound healing, angiogenic capillary sprouts penetrate into the provisional matrix and create microvascular networks (2) . Neovascularizaton involves the dynamic interactions of cells, growth factors, and the matrix. VEGF stimulates and increases neovascularization.
Bone marrow-derived mesenchymal stem cells (BM-MSCs) have the capacity to differentiate along three essential mesenchymal lineages: osteoblasts, adipocytes, chondroblasts (4, 5) . Also, BM-MSCs can express the phenotypic genes of hepatocytes, cardiomyocytes, astrocytes, neurons, and skin-related tissue (6) (7) (8) (9) (10) . There have been reports showing wound healing effectively achieved with the application of BM-MSCs (11, 12) . However, despite increasing knowledge of MSCs, their contribution to wound healing is not understood, and many questions remain. We selected the 3D collagen allograft model, which is most similar to the skin dermis structure, to apply rat MSCs in the collagen gel scaffold composed of rat tail type I collagen in an attempt to maintain the functions of stem cells for a prolonged period. The objective of our study was to investigate the effects of MSCs on wound healing using 3D collagen gel scaffold in vivo.
MATERIALS AND METHODS

Experimental animal model
Eighteen adult female Sprague-Dawley rats, weighing 200 g, were used at 6 weeks of age. All animal procedures were approved under the guidelines approved by the institutional animal care and use committee from Soonchunhyang University. This study was carried out from March 2006 to May 2007 at the Soonchunhyang University. Each rat had free access to both sterile water and standard rodent soft chow ad libitum.
Harvest and culture of MSCs
The bone marrow was harvested from specific pathogen-free, 6-week-old male Sprague-Dawley rats (Charles River Technology). In brief, the rats were killed, and femurs and tibias were removed aseptically. A hole was then created in the knee joint end of each bone with a 26-gauge needle, and marrow was flush ed with phosphate buffered saline (PBS, Gibco BRL, Grand Island, NY, USA) containing 2% fetal bovine serum (FBS, Gibco BRL). The marrow solution was washed by centrifugation at 400 × g for 5 min. The supernatant was aspirated, and the pellet was resuspended in Dulbecco's modified Eagle's medium-low glucose (DMEM-LG, Gibco BRL) containing 10% FBS and 1% penicillin-streptomycin (Gibco BRL). Cells were seeded into 75 cm 2 tissue culture flask and cultured in humidified 5% CO2 incubator at 37°C for 72 hr. Non-adherent cells were removed. When adherent cells reached subconfluence, they were detached with 0.25% trypsin-EDTA solution, and re-seeded at 2 × 10 3 cells/cm 2 . The rat MSCs were used for experiments after the passage 5.
Differentiation of MSCs
For osteogenic differentiation of MSCs, MSCs were maintained with DMEM medium containing 0.1 μM dexamethasone (Sigma, St. Louis, MO, USA), 50 μM ascorbate (Sigma), 10 mM β-glycerol phosphate (Sigma), and 10% FBS for 3 weeks, with the increase of calcium examined using Von Kossa staining.
For adipogenic differentiation of MSCs, MSCs were cultured in DMEM medium (Adipogenic induction, MDI + I) containing 0.1 μM dexamethasone (Sigma), 10 μg/mL insulin (Sigma), 100 mM indomethacin (Sigma), 0.5 mM methyl-isobuthylxanthine (Sigma), and 10% FBS for 72 hr. The medium was changed to DMEM medium (Adipogenic maintenance, AM), containing insulin (10 μg/mL) and 10% FBS for 24 hr. The cells were then re-treated with MDI + I for a second treatment. The cultures were then maintained in AM for 1 week before fixation. Adipogenic differentiation was demonstrated by the accumulation of lipid vesicles with Oil-Red O staining.
For chondrogenic differentiation of MSCs, MSCs were treated with trypsin-EDTA. Then, 2 × 10 5 cells were added to 500 μL of DMEM medium containing 10 -7 M dexamethasone (Sigma), 1 μg/mL TGF-β (R&D Systems, Minneapolis, MN, USA), and 50 μM ascorbic acid 2-phosphate (Sigma), and centrifuged at 1,000 rpm for 5 min. The cells were grown as a pelleted micromass for 3 weeks. The cell pellet was stained with toluidine blue.
Flow cytometric analysis of MSCs
MSCs were trypsinized, washed with PBS, and incubated with antibodies against fluorescein isothiocyanate (FITC)-conjugated CD44H (Pgp-1, BD Biosciences Pharmingen), CD90 (Thy-1, BD), CD11b (Integrin, BD), phycoerythrin (PE)-conjugated CD106 (VCAM-1, BD), and CD45 (BD). Analysis was performed with a flow cytometer (Beckman Coulter, Inc., CA, USA).
Preparation of the three-dimensional collagen gel scaffold
Collagen gel scaffolds were prepared in a sterile tube, by mixing an appropriate volume of rat tail type I collagen (BD Biosciences) to yield a final concentration of 1 mg/mL with medium cocktail (DMEM, NaHCO3 [44 mM/L], L-glutamine [4 mM/L], and folic acid [9 mM/L], neutralized with 1N NaOH to pH 7.2). Collagen solution (1 mL per well of a 6-well plate) was placed in an incubator at 37°C for 30 min to allow polymerization of the collagen.
Assembly of stem cell/collagen tissue construct implants
Control scaffolds were prepared as above. Early passage primary rat MSCs (2 × 10 6 /well) were placed on top of each collagen scaffold and allowed to attach. After attachment, collagen scaffolds were covered with 1 mL of media (DMEM, 10% FBS) and incubated for 72 hr at 37°C, and 5% CO2. The circular MSCs/3D collagen gel scaffolds, at a density of 2 × 10 6 cells for implantation, were 20-mm diameter.
Surgical procedures
In an aseptic surgical room, the rats were anesthetized with intraperitoneal ketamine (60 mg/kg) and xylazine (8 mg/kg). After induction of general anesthesia, the dorsal regions of the rats were shaved. The dorsal skin was disinfected with 10% povidoneiodine and 70% alcohol. Three circular full-thickness defects 20-mm in diameter, including the panniculus carnosus muscle, were created on the back of each rat. One site was covered with 3D collagen gel containing 2 × 10 6 male rat MSCs (MSCs+/3D collagen+ site). Another site replaced with 3D collagen gel without MSCs (MSCs-/3D collagen+) and the third site was left empty (MSCs-/3D collagen-). All wounds were covered with a sterile transparent silicone membrane (Tegaderm, 3M Health Care, St. Paul, MN, USA) to prevent desiccation. Each animal was then housed in its own cage to avoid damage of the wound. Digital pictures were taken to visualize the wound. Wound healing was calculated based on the remaining wound area.
The rats were sacrificed with an overdose of sodium pentobarbital at either 3, 7, 14, or 21 days after wounding. Full-thickness wound tissues, including the adjacent skin, were then harvested, fixed immediately in 10% formalin for 12 hr, embedded in paraffin and sliced into 6-micrometer-thick sections for subsequent immunohistochemistry. For positive controls, normal healthy rat tissues were harvested.
Measurement of wound size
The wound sizes in a standard prone position were photographed using a 334 million d.p.i. digital camera (Canon) and an image analyzer (Image Pro Plus, ver. 5.1; Media Cybernetics) on a personal Microsoft computer. The macroscopic sizes of the remaining wounds were calculated three times for each animal at 0, 3, 7, 14, and 21 days after initial wounding.
Immunohistochemical staining
Paraffin sections were deparaffinized with xylene, rehydrated with 10 mM citrate buffer (pH 6.0) solution, and then treated in a microwave oven for 15 min to restore antigens. To suppress the reaction of endogenous peroxidase within the tissues, the samples were treated with 3% peroxide for 5 min and then with a blocking solution for 30 min. Slides were then placed in a humid chamber and incubated for 60 min with the anti-VEGF antibody (sc-152; Santa Cruz Biotec., Santa Cruz, CA, USA). Tissue staining was visualized with a 3,3´-diaminobenzidine (ACK500; ScyTek, Logan, UT, USA) substrate chromogen solution.
Gelatin zymography
Protein samples (20 μg of protein) were mixed with 2× sample buffer (62.5 mM Tris-HCl pH 6.8, 10% glycerol, 2% SDS, 0.0025 bromphenol blue) and added to the gel without boiling. MMP-2 and MMP-9 activities were analyzed using 10% zymogram gelatin gel (EC6175Box, Invitrogen). 
Statistical analyses
Data were evaluated by analysis of variance (Stacel, add-in software to Microsoft ® Excel 2000). Statistical analyses were performed using the one-way ANOVA followed by Scheffé's multiple-comparison test, and P value of less than 0.05 was considered statistically significant.
RESULTS
Characterization of cultured rat MSCs
When cultured in osteogenic, chondrogenic, and adipogenic medium, they differentiated into osteocytes, chondrocytes, and adipocytes (Fig. 1) . Flow cytometer analysis confirmed expression of stem cell-related surface markers. Cultured adherent cells expressed CD44H and CD90, but not hematopoietic markers such as CD11b, CD45, and CD106 (Fig. 2) . Thus, we confirmed that the adherent cells were mesenchymal stem cells.
Wound size measurements
Each experimental site was relatively of the same size at day 3 due to excision of the panniculus carnosus muscle. The most effective wound healing was observed at day 7 ( Fig. 3) . At day 7, the wound size of MSCs+/3D collagen+ sites was significantly decreased (0.48 ± 0.01 cm ). Also, there was no significant difference between MSCs-/3D collagen+ sites and MSCs-/3D collagen-sites (Fig. 4) . MSCs+/3D collagen+ sites demonstrated accelerated wound healing. Since there was a possibility that the rate of wound healing could vary with the defect position, we repeated the same procedure by changing the positions of the defect sites, which yielded similar results.
Immunohistochemistry
The tissue samples from each experimental group at day 7, when stained with VEGF antibody, showed that MSCs+/3D collagen+ sites exhibited the most distinct neovascularization compared to other sites (Fig. 5 ).
X and Y chromosome fluorescence in situ hybridization
Y-chromosomes were probed with spectrum red (Cy3), whereas X-chromosomes with spectrum green (FITC). FISH analysis showed that many Y-chromosome positive cells were identified within the dermis of MSCs+/3D collagen+ sites at day 7 (Fig. 6 ).
Gelatin zymography
We used the gelatin zymography to assess the expression status of MMP-2 (72-kDa/gelatinase A) and MMP-9 (92-kDa/gelatinase B). MMP-2 was expressed in all experimental sites, including normal rat skin tissue, at day 3 and day 7. MMP-9 was not detected in normal tissue, but expressed in MSCs-/3D collagen+ sites, MSCs-/3D collagen-sites, and MSCs+/3D collagen+ sites. Interestingly, MMP-9 was expressed most intensively early in MSCs+/3D collagen+ sites at day 3. However, by day 7, MMP-9 was weakly expressed in MSCs+/3D collagen+ sites compared to MSCs-/3D collagen+ and MSCs-/3D collagen-sites (Fig. 7) . 
DISCUSSION
Wound healing is a complex process requiring the proper expression of signaling molecules and receptors, cellular adhesion molecules, and ECM proteins. These molecules are processed by MMPs and regulate many processes of wound healing (13) . MMPs contribute too many aspects of tissue regeneration and angiogenesis by promoting the release of ECM-bound cytokines or angiogenesis-modulating ECM fragments (14) . Recent studies have reported that implanted MSCs accelerate the restoration of damaged tissue (15) (16) (17) . With regard to tissue regeneration, this potency of MSCs may play a more principal role than X Y trans-differentiation (18) . In the present study, MSCs+/3D collagen+ sites significantly reduced the wound size and exhibited the most intense expression of VEGF. VEGF is a potent angiogenic factor that stimulates angiogenesis in vivo (19) (20) (21) . Angiogenesis is a complex and dynamic process which is affected by many factors including growth factors, cytokines, and ECM (22) . The expression of VEGF is thought to be potentiated in response to the activation of bioactive molecules, and VEGF is considered to mediate angiogenic activity during the early period of wound healing.
There are interesting differences between MMP-2 and MMP-9 by gelatin zymography. MMP-2 was expressed in all experimental sites including normal rat skin tissue. This finding indicates that MMP-2 plays a less important role in early tissue metabolism. MMP-9 was expressed in MSCs+/3D collagen+ sites, MSCs-/3D collagen+ sites, and MSCs-/3D collagen+ sites, but not in normal rat skin tissue. Interestingly, during the early healing period (day 3), MMP-9 was most intensively expressed in MSCs+/3D collagen+ sites. In the later period (day 7), however, MMP-9 was more weakly expressed in MSCs+/3D collagen+ sites, compare to MSCs-/3D collagen+ sites and MSCs-/3D collagen-sites. This suggests that MMP-9 is involved in the early period of wound healing which coincides with enhanced wound healing process via angiogenesis. This is in good agreement with the findings that many processes are involved in the early period of wound healing require the action of proteases to facilitate cell movement, tissue degradation, granulation tissue formation and angiogenesis (1, 2) . Hence, MMP-9, which is expressed early in MSCs+/3D collagen+ sites, appears to play critical roles in initiating angiogenesis.
There are reports that MMP-9, but not MMP-2, stimulates the production and secretion of VEGF in retinal pigment epithelial cells (23) , and that inhibition of MMP-9 attenuates VEGF-induced intracerebral hemorrhage (24) . Upon secretion, VEGF becomes bound to the ECM (25) , and the interaction of VEGF with ECM proteins is mediated via ECM-binding domain. VEGF is encoded by a single gene and the coding portion contains eight exons (26) . Exon 6 and 7 have been demonstrated to encode the ECM-binding domain of the protein. This domain can bind matrix proteins and is considered to account for the sequestration of VEGF within the ECM (27, 28) . Thus, VEGF becomes liberated by ECM degradation through MMPs. Their effects are due to the mobilization of VEGF release through the degradation of ECM proteins by MMPs. In this study, VEGF and MMP were expressed in MSCs+/3D collagen+ sites. These factors may have an effect in a single manner or rather interact with each other. Early expressed MMP-9 promotes the release of extracellular matrix-bound cytokines, VEGF, which regulates angiogenesis. In the present study, MSCs upregulate the early expression of MMP-9, not MMP-2. This early upregulation of MMP-9 seems to be the crucial steps in angiogenesis.
In the present study, we used a three-dimensional collagen gel scaffold. In vivo, cells within the tissue are surrounded by complex three-dimensional microenvironments. Three-dimensional scaffolds possibly give an appropriate cell density and mimic ECM microenvironments in vivo. The main structural element of the ECM is collagen type-I which is why 3D collagen scaffolds have been frequently used. Up to our knowledge, there is no prior study dealing with 3D collagen and MSCs in wound healing. The 3D collagen gel scaffold is constitutionally suited, therefore, stably introduces MSCs to the experimental sites.
There have been reports stating that adult stem cells demonstrate a low level of engraftment (29, 30) . At day 7, within the dermis of MSCs+/3D collagen+ sites, we detected Y-chromosome possessing cells in FISH and VEGFs were expressed in large amounts by immunohistochemistry. These Y-chromosome possessing MSCs and increased VEGFs, are expressed early in MSCs+/3D collagen+ sites, are most likely to promote dermal remodeling, since they were observed in the dermis of MSCs+/3D collagen+ sites. MSCs+/3D collagen+ site enhances pro-angiogenic properties by early induction of MMP-9 and VEGF.
In conclusion, early expression of MMP-9 and VEGF, as part of an underlying mechanism of accelerated wound healing, play 
